Patents by Inventor Terry J. Opgenorth

Terry J. Opgenorth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histamine-3 receptor ligands for diabetic conditions
    Publication number: 20030153548
    Abstract: The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.
    Type: Application
    Filed: December 23, 2002
    Publication date: August 14, 2003
    Inventors: Arthur A. Hancock, Eugene N. Bush, Marlon D. Cowart, Peer B. Jacobson, Terry J. Opgenorth, Youssef Bennani
  • Endothelin converting enzyme inhibitors
    Patent number: 5338726
    Abstract: Compounds are disclosed which inhibit endothelin converting enzyme. These compounds are useful for treating hypertension, congestive heart failure, myocardial infarction, reperfusion injury, coronary angina, cerebral vasospasm, acute renal failure, non-steroidal antiinflammatory drug induced gastric ulceration, cyclosporin induced nephrotoxicity, endotoxin-induced toxicity, asthma and atherosclerosis.
    Type: Grant
    Filed: September 29, 1992
    Date of Patent: August 16, 1994
    Assignee: Abbott Laboratories
    Inventors: Kazumi Shiosaki, Andrew S. Tasker, Terry J. Opgenorth